Predicting human pharmacokinetics from preclinical data: volume of distribution

利用临床前数据预测人体药代动力学:分布容积

阅读:1

Abstract

This tutorial introduces background and methods to predict the human volume of distribution (V(d)) of drugs using in vitro and animal pharmacokinetic (PK) parameters. The physiologically based PK (PBPK) method is based on the familiar equation: V(d) = V(p) + ∑ (T) (V(T) × k(tp) ). In this equation, V(p) (plasma volume) and V(T) (tissue volume) are known physiological values, and k(tp) (tissue plasma partition coefficient) is experimentally measured. Here, the k(tp) may be predicted by PBPK models because it is known to be correlated with the physicochemical property of drugs and tissue composition (fraction of lipid and water). Thus, PBPK models' evolution to predict human V(d) has been the efforts to find a better function giving a more accurate k(tp). When animal PK parameters estimated using i.v. PK data in ≥ 3 species are available, allometric methods can also be used to predict human V(d). Unlike the PBPK method, many different models may be compared to find the best-fitting one in the allometry, a kind of empirical approach. Also, compartmental V(d) parameters (e.g., V(c), V(p), and Q) can be predicted in the allometry. Although PBPK and allometric methods have long been used to predict V(d), there is no consensus on method choice. When the discrepancy between PBPK-predicted V(d) and allometry-predicted V(d) is huge, physiological plausibility of all input and output data (e.g., r(2)-value of the allometric curve) may be reviewed for careful decision making.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。